Trial intelligence / Profile preview

Tiotropium in African American COPD Patients

NCT00106821Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Jun 2004
Primary completion
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Jun 2004; status: completed.

02

Drugs

tiotropium
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00106821.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00106821.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call